Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
HNO ; 51(10): 800-5, 2003 Oct.
Article in German | MEDLINE | ID: mdl-14523533

ABSTRACT

BACKGROUND: In recent years, a number of molecular markers have been tested for their potential to predict the outcome after radiotherapy or radiochemotherapy in patients with advanced head and neck squamous cell carcinomas (HNSCC). These studies have produced controversial results. PATIENTS AND METHODS: The expression patterns of the proteins p53, pRb, cyclinD1, cdk4, p21(CIP1/WAF1), p16(INK4a), bcl-2, and mib-1/ki-67 were analyzed in pretreatment tumor biopsies of 53 patients with advanced nonresectable head and neck squamous cell carcinomas (mainly UICC IV). The patterns obtained were compared with clinical outcome after accelerated radiochemotherapy with carboplatin and 5-fluorouracil or accelerated fractionated radiotherapy alone, respectively. RESULTS: The expression patterns of the proteins examined did not correlate with response to therapy or with further clinical course. CONCLUSION: In patients with advanced head and neck squamous cell carcinomas, the prognostic relevance of pretreatment expression patterns of the proteins investigated in this study, particularly p53, cyclinD1, and cdk4, has to be questioned.


Subject(s)
Biomarkers, Tumor/genetics , Carcinoma, Squamous Cell/pathology , Cell Cycle Proteins/genetics , Otorhinolaryngologic Neoplasms/pathology , Adult , Aged , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/therapy , Combined Modality Therapy , Female , Gene Expression Regulation, Neoplastic/physiology , Humans , Immunohistochemistry , Lymph Nodes/pathology , Lymphatic Metastasis/pathology , Male , Middle Aged , Neoplasm Staging , Otorhinolaryngologic Neoplasms/genetics , Otorhinolaryngologic Neoplasms/therapy , Prognosis , Sensitivity and Specificity
2.
HNO ; 47(9): 777-86, 1999 Sep.
Article in German | MEDLINE | ID: mdl-10525606

ABSTRACT

BACKGROUND: Primary radiochemotherapy is gaining increasing importance for the treatment of advanced head and neck squamous cell carcinomas. However, there is a lack of clinical factors concerning prognostic information in relation to treatment. In this pilot study, we examined whether molecular factors can provide such information. PATIENTS AND METHODS: The expression patterns and their possible prognostic relevance of the cell cycle regulatory proteins p53, p21(WAF/CIP1), Rb, p16(INK4A), CDK4 and Cyclin D1, MIB1 (Ki-67) and BCL-2 were analysed in pretreatment tumor biopsies from 43 patients with advanced carcinomas of the oropharynx (n = 26), hypopharynx (n = 10) and larynx (n = 7) by applying immunohistochemistry to paraffin sections of tumor specimens. All patients were treated by the same method of an accelerated "concomitant boost" radiochemotherapy with carboplatin in a phase II study. Median followup time was 56 months. RESULTS: No correlation was found between any of the markers and the remission rate, T-stage, N-stage, rate of loco-regional recurrences and distant metastases. However, independent of the tumor stage, patients with CDK4/cyclin-D1 overexpressing tumors had a significantly shortened overall survival (P = 0.014 and 0.026, respectively). CONCLUSION: The results of this pilot study indicate that CDK4 and cyclin D1 over-expression provide useful prognostic information about clinical outcome after primary radiochemotherapy of head and neck cancer patients.


Subject(s)
Biomarkers, Tumor/genetics , Carcinoma, Squamous Cell/genetics , Cell Cycle Proteins/genetics , Otorhinolaryngologic Neoplasms/genetics , Adult , Aged , Antineoplastic Agents/administration & dosage , Carboplatin/administration & dosage , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/radiotherapy , Combined Modality Therapy , Gene Expression Regulation, Neoplastic/physiology , Humans , Male , Middle Aged , Neoplasm Staging , Otorhinolaryngologic Neoplasms/drug therapy , Otorhinolaryngologic Neoplasms/pathology , Otorhinolaryngologic Neoplasms/radiotherapy , Pilot Projects , Prognosis , Radiotherapy Dosage
3.
HNO ; 47(9): 796-803, 1999 Sep.
Article in German | MEDLINE | ID: mdl-10525608

ABSTRACT

In order to identify squamous cell carcinomas of the head and neck (HNSCC) with common biological and clinical features, we investigated the incidence and properties of carcinomas lacking retinoblastoma protein (pR6) cell cycle control. Of 208 HNSCC investigated, 23 (11%) showed a lack of pRb expression. The majority of these tumors (65%) were tonsillar carcinomas. The pRb-negative tonsillar tumors were all stage IV, had metastasized to lymph nodes at the time of diagnosis and were in general poorly differentiated or undifferentiated. Very significantly, the pRb-negative phenotype was strongly associated with the presence of oncogenic human papilloma viruses, implying a viral etiology and functional inactivation of pRb by the viral E7 oncoprotein. Despite the very adverse histopathological factors, patients with pRb-negative tonsillar carcinomas had a better clinical outcome, which was consistent with a uniform favorable responsiveness of these tumors to postoperative radiation therapy.


Subject(s)
Carcinoma, Squamous Cell/genetics , Papillomaviridae/genetics , Papillomavirus Infections/genetics , Retinoblastoma Protein/genetics , Tonsillar Neoplasms/genetics , Carcinoma, Squamous Cell/pathology , Gene Expression Regulation, Neoplastic/physiology , Gene Expression Regulation, Viral/physiology , Humans , Lymphatic Metastasis , Neoplasm Staging , Oncogene Proteins, Viral/genetics , Palatine Tonsil/pathology , Papillomavirus E7 Proteins , Papillomavirus Infections/pathology , Prognosis , Tonsillar Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...